← Back to Search

Screening tool group for Focus Groups (ACCESS Trial)

N/A
Recruiting
Led By Nihal Mohamed, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2023-2025
Awards & highlights

ACCESS Trial Summary

The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer will be included in this study and asked to participate in a focus group, complete a screening tool, or complete a survey. All data collected will be linked to a study ID number and HIPAA identifiers will not be linked to study data. Identifying information (ie: name, mrn, email, phone number) will be utilized for study recruitment and identifying eligible patients. Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational advancement, or reputation.

Eligible Conditions
  • Focus Groups
  • Questionnaire

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2023-2025
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2023-2025 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Bladder Cancer Need Assessment Survey (BCNAS)

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Group I: Screening tool groupExperimental Treatment1 Intervention
Group II: Focus groupExperimental Treatment0 Interventions

Find a Location

Who is running the clinical trial?

PfizerIndustry Sponsor
4,582 Previous Clinical Trials
14,634,587 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiLead Sponsor
871 Previous Clinical Trials
527,041 Total Patients Enrolled
Nihal Mohamed, PhDPrincipal InvestigatorIcahn School of Medicine
2 Previous Clinical Trials
111 Total Patients Enrolled
~129 spots leftby Nov 2025